Complete Filing Data
NYMOX PHARMACEUTICAL CORP reported Research And Development Expense of $3.28 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean NYMOX PHARMACEUTICAL CORP did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research And Development Expense | $3.3M | $4.0M | $3.8M | $6.7M | $8.1M | $7.4M | $6.7M | $7.9M | $6.8M | $8.7M |
| Revenue From Sale Of Goods | $0.00 | $0.00 | $0.00 | $5.0K | $116.0K | $299.0K | $224.0K | $284.0K | $253.0K | |
| Cost Of Sales | $0.00 | $0.00 | $0.00 | $4.0K | $58.0K | $138.0K | $149.0K | $173.0K | $160.0K | |
| Profit Loss Before Tax | -$4.5M | -$8.8M | -$6.6M | -$12.5M | -$11.7M | -$163.0K | -$10.6M | -$13.4M | -$13.1M | -$17.9M |
| Profit Loss | -$4.5M | -$8.8M | -$6.6M | -$12.5M | -$11.7M | -$13.2M | -$10.6M | -$13.4M | -$13.1M | -$17.9M |
| Profit Loss From Operating Activities | -$4.3M | -$8.4M | -$6.7M | -$12.5M | -$11.7M | -$13.3M | -$10.6M | -$13.2M | -$12.9M | -$17.7M |
| Selling General And Administrative Expense | $1.0M | $4.4M | $2.9M | $5.8M | $3.6M | $6.0M | $4.1M | $5.4M | $6.2M | $11.6M |
| Sales And Marketing Expense | $8.0K | $7.0K | $10.0K | |||||||
| Income Tax Expense Continuing Operations | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Operating Lease Interest Expense | $0.00 | $3.0K | $15.0K | $19.0K | -$12.0K | -$20.0K | $0.00 | |||
| Income Taxes Paid Refund | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Profit Loss Attributable To Owners Of Parent | -$4.5M | -$8.8M | -$6.6M | -$12.5M | -$11.7M | -$13.2M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $830.0K | $3.6M | $5.2M | $7.9M | $851.0K | $2.0M | $374.0K | $632.0K | |||
| Cash Flows From Used In Operating Activities | -$2.6M | -$4.1M | -$5.2M | -$9.8M | -$10.0M | -$7.4M | -$7.8M | -$6.2M | -$4.5M | -$3.8M | |
| Cash Flows From Used In Financing Activities | $2.6M | $2.7M | $5.8M | $7.0M | $8.4M | $4.7M | $14.9M | $5.0M | $6.1M | $3.5M | |
| Property Plant And Equipment | $1.0K | $2.0K | $10.0K | $22.0K | $28.0K | $25.0K | $33.0K | $1.0K | $2.0K | $3.0K | |
| Other Receivables | $27.0K | $11.0K | $10.0K | $13.0K | $20.0K | $14.0K | $12.0K | $8.0K | $3.0K | $7.0K | |
| Liabilities | $7.4M | $3.8M | $2.1M | $1.9M | $2.2M | $2.0M | $1.1M | $2.2M | $2.3M | $3.1M | |
| Equity And Liabilities | $654.0K | $627.0K | $1.6M | $1.4M | $4.3M | $5.5M | $8.1M | $979.0K | $2.1M | $712.0K | |
| Current Assets | $653.0K | $625.0K | $1.5M | $1.0M | $3.9M | $5.3M | $8.0M | $961.0K | $2.0M | $692.0K | |
| Assets | $654.0K | $627.0K | $1.6M | $1.4M | $4.3M | $5.5M | $8.1M | $979.0K | $2.1M | $712.0K | |
| Share Capital Subscription Receivable | $0.00 | $0.00 | $0.00 | -$589.0K | -$589.0K | -$589.0K | -$868.0K | -$718.0K | |||
| Retained Earnings | -$212.5M | -$208.0M | -$199.1M | -$192.6M | -$180.0M | -$168.3M | -$155.1M | -$144.5M | -$131.1M | -$118.0M | |
| Current Liabilities | $7.4M | $3.8M | $2.1M | $1.8M | $2.0M | $2.0M | $1.1M | $2.2M | |||
| Adjustments For Decrease Increase In Trade And Other Receivables | -$16.0K | -$1.0K | $3.0K | $7.0K | -$1.0K | -$4.0K | $73.0K | -$77.0K | -$2.0K | $52.0K | |
| Cash Flows From Used In Investing Activities | $0.00 | -$3.0K | $0.00 | -$6.0K | -$13.0K | $0.00 | -$36.0K | -$2.0K | |||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $0.00 | $3.0K | $0.00 | $6.0K | $13.0K | $0.00 | $36.0K | $2.0K | |||
| Trade And Other Current Payables | $1.8M | $1.9M | $1.1M | $2.2M | $1.4M | $2.3M | |||||
| Adjustments For Increase Decrease In Trade And Other Payables | -$172.0K | $819.0K | -$1.2M | $863.0K | -$883.0K | $318.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $74.0K | $70.0K | $1.4M | $830.0K | $3.6M | $5.2M | |||||
| Trade And Other Current Receivables | $4.0K | $2.0K | $79.0K | $6.0K | $1.0K | ||||||
| Adjustments For Increase Decrease In Other Current Liabilities | -$180.0K | -$18.0K | -$1.0K | -$1.0K | |||||||
| Shares Issuance For Cash And Subscriptions Amount | 1.2M | 4.3M | 7.0M | 8.7M | 5.1M | 14.9M | |||||
| Adjustments For Increase Decrease In Trade Account Payable | $1.2M | $1.3M | $376.0K | -$165.0K | -$172.0K | ||||||
| Repayment Of Operating Lease And Financing Obligation | -$229.0K | -$238.0K | -$265.0K | -$277.0K | $0.00 | ||||||
| Operating Lease Liability Due Within One Year | $173.0K | $228.0K | $193.0K | $144.0K | $0.00 | ||||||
| Lease Liabilities | $0.00 | $0.00 | $173.0K | ||||||||
| Current Accrued Expenses And Other Current Liabilities | $4.1M | $3.1M | $1.9M | ||||||||
| Other Current Financial Liabilities | $368.0K | $3.0K | $0.00 | $931.0K | $814.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Cash And Cash Equivalents | $4.0K | -$1.3M | $573.0K | -$2.8M | -$1.6M | -$2.7M | $7.1M | -$1.2M | $1.6M | -$258.0K |
| Proceeds From Issuing Shares | 0.00 | 1.2M | 6.0M | 7.3M | 8.7M | 5.0M | 14.9M | 5.0M | 6.1M | 3.6M |
| Payments Of Lease Liabilities Classified As Financing Activities | $64.0K | $173.0K | $229.0K | $238.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Shares | 93.7M | 91.7M | 89.4M | 82.0M | 73.8M | 68.8M | 60.5M | 52.6M | 46.2M | 37.4K |
| Basic And Diluted Earnings Loss Per Share | $-0.16 | $-0.19 | $-0.18 | $-0.26 | $-0.28 | $-0.48 | ||||
| Number Of Shares Outstanding | 94.5M | 93.5M | 71.2M | 64.7M | 56.4M | 49.1M | ||||
| Basic Earnings Loss Per Share | $-0.05 | $-0.10 | $-0.07 | $-0.15 | $-0.16 | $-0.19 | ||||
| Share Capital Shares Outstanding | 93.5M | 90.5M | 85.5K | 78.0K | 71.2M | 64.7M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments For Sharebased Payments | $671.0K | $3.4M | $593.0K | $2.6M | $1.7M | $3.0M | $3.8M | $6.3M | $9.1M | $15.8M |
| Current Prepaid Expenses | $16.0K | $16.0K | $16.0K | $132.0K | $200.0K | $20.0K | $2.0K | $1.0K | $1.0K | $1.0K |
| Additional Paidin Capital | $28.0M | $27.8M | $27.0M | $27.6M | $31.0M | $35.8M | $36.3M | $35.8M | $38.7M | $30.7M |
| Expense By Nature | $4.3M | $8.4M | $6.7M | $12.5M | $11.7M | $13.4M | $10.9M | $13.5M | $13.2M | $20.4M |
| Issued Capital | $173.9M | $173.8M | $171.7M | $165.1M | $151.7M | $136.6M | $126.7M | $108.2M | $92.1M | $85.0M |
| Inventories | $0.00 | $34.0K | $34.0K | $23.0K | $41.0K | $15.0K | $3.0K | $38.0K | ||
| Finance Costs | $226.0K | $58.0K | $28.0K | $20.0K | -$30.0K | $18.0K | $18.0K | -$204.0K | -$244.0K | -$234.0K |
| Adjustments For Decrease Increase In Inventories | $0.00 | $0.00 | -$11.0K | $17.0K | -$25.0K | -$13.0K | $35.0K | $51.0K | ||
| Security Deposit | $36.0K | $28.0K | $28.0K | $28.0K | $28.0K | $28.0K | $23.0K | $17.0K | ||
| Adjustments For Depreciation Expense | $9.0K | $9.0K | $3.0K | $1.0K | $3.0K | $6.0K | ||||
| Security Deposit1 | $28.0K | $23.0K | $7.0K | $7.0K | ||||||
| Depreciation Expense | $1.0K | $11.0K | $12.0K | $12.0K | $9.0K | |||||
| Amortisation Expense | $0.00 | $158.0K | $237.0K | $242.0K | $258.0K | |||||
| Stock Based Compensation And Service Fee Amount | $671.0K | $3.4M | $593.0K | $2.6M | $1.7M | $4.3M | ||||
| Interest Paid Refund | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Adjustments For Increase Decrease In Deposits From Banks | $0.00 | -$500.0K | $12.0K | -$16.0K | -$7.0K | |||||
| Warrant Issued | $0.00 | $440.0K | $1.7M | $330.0K | $200.0K | |||||
| Adjustments For Decrease Increase In Prepaid Expenses | $116.0K | $68.0K | -$180.0K | |||||||
| Other Income | $0.00 | $0.00 | $113.0K | $0.00 | $0.00 | |||||
| Amortization And Others | $242.0K | $258.0K | $556.0K | $0.00 | ||||||
| Shares And Warrants Issued On Connection With Convertible Notes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.2M | 58.0K |
Most recent annual filing with the SEC: June 3, 2025
Data sourced from SEC EDGAR public filings as of August 7, 2026.